| For: | Roy A, Sahoo J, Kamalanathan S, Naik D, Mohan P, Kalayarasan R. Diabetes and pancreatic cancer: Exploring the two-way traffic. World J Gastroenterol 2021; 27(30): 4939-4962 [PMID: 34497428 DOI: 10.3748/wjg.v27.i30.4939] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v27/i30/4939.htm |
| Number | Citing Articles |
| 1 |
O. Yu. Usenko, V. V. Petrushenko, S. A. Sukhodolia, A. I. Sukhodolia, O. M. Savchuk, Ia. V. Radoga, I. I. Savchuk . Optimization of the selection of the volume of surgical intervention in cases of pronounced morphological and structural changes of the parenchyma in patients with a high risk of developing pancreatic cancer. Reports of Morphology 2024; 30(1) doi: 10.31393/morphology-journal-2024-30(1)-06
|
| 2 |
Colton D. Wayne, Chahrazed Benbetka, Gail E. Besner, Siddharth Narayanan. Challenges of Managing Type 3c Diabetes in the Context of Pancreatic Resection, Cancer and Trauma. Journal of Clinical Medicine 2024; 13(10) doi: 10.3390/jcm13102993
|
| 3 |
Dhruv Sanjay Gupta, Daksh Sanjay Gupta, Saritha R. Shetty. Biosimilars for Cancer Treatment. 2024; doi: 10.1007/978-981-97-3001-8_9
|
| 4 |
Yuxuan Huang, Shuhan Ju, Shanyi Li. Research progress on the association between diabetes mellitus and risk of cancer: From epidemiology to molecular mechanisms. Biochemical and Biophysical Research Communications 2026; 829 doi: 10.1016/j.bbrc.2026.154205
|
| 5 |
Haopeng Li, Yaru Zu, Qinghua Wang, Tong Zi, Xin Qin, Yan Zhao, Wei Jiang, Xin’an Wang, Chengdang Xu, Xi Chen, Gang Wu. Risk factor analysis and nomogram development for predicting 28-day mortality in elderly ICU patients with sepsis and type 2 diabetes mellitus. European Journal of Inflammation 2024; 22 doi: 10.1177/1721727X241282483
|
| 6 |
Haoran Zhao, Yubao Zhang, Haishi Liu, Yunfeng Wang, Zengfu Song. Age-period-cohort analysis of global, regional, and national pancreatic cancer incidence, mortality, and disability-adjusted life years, 1990–2019. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12835-0
|
| 7 |
Daniel Paramythiotis, Georgia Fotiadou, Eleni Karlafti, Ioanna Abba Deka, Georgios Petrakis, Elisavet Psoma, Xanthippi Mavropoulou, Filippos Kyriakidis, Smaro Netta, Stylianos Apostolidis. Synchronous Pancreatic Ductal Adenocarcinoma in the Head and Tail, a Double Trouble: A Case Report and Literature Review. Diagnostics 2022; 12(11) doi: 10.3390/diagnostics12112709
|
| 8 |
Natalia Khalaf, Jennifer Kramer, Yan Liu, Daniela Abrams, Hardeep Singh, Hashem El-Serag, Fasiha Kanwal. Diabetes Status and Pancreatic Cancer Survival in the Nationwide Veterans Affairs Healthcare System. Digestive Diseases and Sciences 2023; 68(9) doi: 10.1007/s10620-023-08035-8
|
| 9 |
Yewon Na, Soo Wan Kim, Ie Byung Park, Soo Jung Choi, Seungyoon Nam, Jaehun Jung, Dae Ho Lee. Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes. The Journal of Clinical Endocrinology & Metabolism 2022; 107(11) doi: 10.1210/clinem/dgac540
|
| 10 |
Sihao Han, Adelynn Paik, Jared Acoba, Lynne R. Wilkens, Loïc Le Marchand, Brian Z. Huang. Risk Factor Profiles and Elevated Incidence of Pancreatic Cancer in Native Hawaiians. American Journal of Gastroenterology 2026; 121(1) doi: 10.14309/ajg.0000000000003655
|
| 11 |
Yuxin Wang, Lu Xie, Ye Gu, Hangbin Jin, Jianfeng Yang, Qiang Liu, Xiaofeng Zhang. Complex interplay between type 2 diabetes mellitus and pancreatic cancer: insights from observational and mendelian randomization analyses. BMC Cancer 2025; 25(1) doi: 10.1186/s12885-025-13976-6
|
| 12 |
Catharina B.P. Villaca, Teresa L. Mastracci. Pancreatic Crosstalk in the Disease Setting: Understanding the Impact of Exocrine Disease on Endocrine Function. Comprehensive Physiology 2024; 14(2) doi: 10.1002/j.2040-4603.2024.tb00294.x
|
| 13 |
Shreya Singh, Anupama Sawal. Comprehensive Review on Pancreatic Head Cancer: Pathogenesis, Diagnosis, and Treatment Challenges in the Quest for Improved Survival. Cureus 2024; doi: 10.7759/cureus.54290
|
| 14 |
Hanife Usta Atmaca, Feray Akbas, Hatice Ozkul, Cigdem Usul Afsar, Ozlem Yılmaz. The Relationship Between Metabolic and Inflammatory Parameters at the Time of Diagnosis and Disease Stage and Prognosis in Patients with Pancreatic Cancer. Metabolic Syndrome and Related Disorders 2025; 23(6) doi: 10.1089/met.2024.0210
|
| 15 |
Dooyeon Lee, Mun Sem Liew, Spiros Fourlanos, Julian Choi. Metformin use and pancreatic ductal adenocarcinoma outcomes: a narrative review. ANZ Journal of Surgery 2025; 95(3) doi: 10.1111/ans.19405
|
| 16 |
Anna Schranz, Christoph Sternad, Faisal Aziz, Doris Wagner, Peter Kornprat, Robert Sucher, Philipp J. Jost, Albert Wölfler, Thomas R. Pieber, Harald Sourij, Jakob M. Riedl, Felix Aberer. Incidence of Diabetes Mellitus and Its Impact on Outcomes in Patients Undergoing Surgical Pancreatectomy for Non-Malignant and Malignant Pancreatobiliary Diseases—A Retrospective Analysis. Journal of Clinical Medicine 2023; 12(24) doi: 10.3390/jcm12247532
|
| 17 |
V. V. Petrushenko, S. A. Sukhodolia, A. I. Sukhodolia, Ia. V. Radoga, Ye. Rudnichenko. Mathematical model of diagnostics of malignant pancreas pathology. Reports of Vinnytsia National Medical University 2024; 28(1) doi: 10.31393/reports-vnmedical-2024-28(1)-12
|
| 18 |
Chukwuemeka Ogbu, Yichen Wang, Oyedotun Babajide, Chukwunonso Ezeani, Lekhya Kollu, Osayande Osagiede, Philip N. Okafor. The Coexistence of Diabetes Mellitus and Low Fecal Elastase Is Associated With Increased Pancreatic Cancer Risk: A Retrospective, Real-world Cohort Study. Pancreas 2026; 55(4) doi: 10.1097/MPA.0000000000002592
|
| 19 |
Valeria Tonini, Manuel Zanni. Early diagnosis of pancreatic cancer: What strategies to avoid a foretold catastrophe. World Journal of Gastroenterology 2022; 28(31): 4235-4248 doi: 10.3748/wjg.v28.i31.4235
|
| 20 |
O. Usenko, S. Sukhodolia, A. Sukhodolia, O. Savchuk. Results of surgical treatment of chronic pancreatitis with a high risk of developing pancreatic cancer. The Ukrainian Journal of Clinical Surgery 2024; 91(4) doi: 10.26779/2786-832X.2024.4.27
|
| 21 |
Dipanwita Nath, Caitlin Ditchfield, Joshua Price, Shivan Sivakumar, Simon W. Jones, Animesh Acharjee. Linking Targeted Pancreatic Cancer Genes With Metabolic Disorders: A Cross‐Species Translational Pathway. Cancer Medicine 2026; 15(4) doi: 10.1002/cam4.71775
|
| 22 |
Laura Antolino, Germana de Nucci, Stefania Scarpino, Giuseppe Bianco, Gianluca Lopez, Paolo Aurello, Niccolò Petrucciani, Roberto Santoro, Giuseppe Nigri, Salvatore Agnes, Gianpiero Manes, Francesco A. D’Angelo. Association of TP53 Arg72Pro (rs1042522) Polymorphism with Pancreatic Cancer Risk in a Patient Cohort. Onco 2025; 5(4) doi: 10.3390/onco5040044
|
| 23 |
Chunlei Zheng, Asif Khan, Daniel Ritter, Debora S. Marks, Nhan V. Do, Nathanael R. Fillmore, Chris Sander. Pancreatic cancer risk prediction using deep sequential modeling of longitudinal diagnostic and medication records. Cell Reports Medicine 2025; 6(9) doi: 10.1016/j.xcrm.2025.102359
|
| 24 |
Yu-Wei Ling, Juan-Li Duan, Zi-Jian Jiang, Zhen Yang, Jing-Jing Liu, Ping Song, Zhi-Qiang Fang, Zhen-Sheng Yue, Fei He, Ke-Feng Dou, Lin Wang. Diabetes reshapes pancreatic cancer-associated endothelial niche by accelerating senescence. Nature Communications 2025; 16(1) doi: 10.1038/s41467-025-63801-8
|
| 25 |
Melissa Heller, Derek A. Mann, Bryson W. Katona. Current Approaches of Pancreatic Cancer Surveillance in High-Risk Individuals. Journal of Gastrointestinal Cancer 2025; 56(1) doi: 10.1007/s12029-025-01184-1
|
| 26 |
Jingchang Zhang, Jianbiao Li, Huiting Deng, Yongfu Zhao, Ye Zhang. Metabolic syndrome as a prognostic factor in advanced pancreatic cancer: a predictive model and chemotherapy evaluation. World Journal of Surgical Oncology 2025; 23(1) doi: 10.1186/s12957-025-03940-w
|
| 27 |
Xinzhe Zhu, Huaxiang Xu, Zhiwen Xiao, He Liu, Quanxing Ni, Xianjun Yu, Guopei Luo. Hyperglycemia predicts adverse prognosis in advanced pancreatic cancer patients. Endocrine 2023; 79(2) doi: 10.1007/s12020-022-03196-4
|
| 28 |
Cheng Qin, Tianyu Li, Chen Lin, Bangbo Zhao, Zeru Li, Yutong Zhao, Weibin Wang. The systematic role of pancreatic cancer exosomes: distant communication, liquid biopsy and future therapy. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03456-5
|
| 29 |
Pengbo Gao, Chunxiao Wang, Sihan Wang, Xiaoce Cai, Jiao Wang, Xiaoying Sun, Fengming Hu, Xin Li. Early diagnosis of type 2 diabetes mellitus in patients with psoriasis: Construction of a multifactorial diagnostic model. Journal of the American Academy of Dermatology 2025; 92(4) doi: 10.1016/j.jaad.2024.11.066
|
| 30 |
Qiuwen Lou, Jie Chang, Yi Pan, Yuzhuo Gong, Wenxia Xu, Minfeng Tong, Lude Wang, Fengfeng Jiang. Regulatory mechanisms of PFKFB2 in glycolysis and tumor metabolism: implications for cancer therapy. Carcinogenesis 2025; 46(2) doi: 10.1093/carcin/bgaf022
|
| 31 |
Daniel Vasile Balaban, Laura Coman, Marina Balaban, Andreea Zoican, Danusia Adriana Pușcașu, Simin Ayatollahi, Emanuela Mihălțeanu, Raluca Simona Costache, Florentina Ioniță-Radu, Mariana Jinga. Glycemic Abnormalities in Pancreatic Cystic Lesions—A Single-Center Retrospective Analysis. Gastroenterology Insights 2023; 14(2) doi: 10.3390/gastroent14020015
|
| 32 |
Sho Kiritani, Yoshihiro Ono, Manabu Takamatsu, Sachiyo Yoshio, Mamiko Miyashita, Atsushi Oba, Takafumi Sato, Hiromichi Ito, Yosuke Inoue, Akio Saiura, Yu Takahashi. Unique Biology of Pancreatic Ductal Adenocarcinoma Accompanied by Rapidly Impaired Diabetes: A Favorable Long-Term Survival Following Curative Resection. Annals of Surgical Oncology 2024; 31(1) doi: 10.1245/s10434-023-14408-0
|
| 33 |
Jung Won Chun, Young Hoon Choi. Recent Perspectives on Surveillance Strategies in High-risk Individuals with Pancreatic Cancer. Journal of Digestive Cancer Research 2026; 14(1) doi: 10.52927/jdcr.2026.14.1.33
|
| 34 |
Zheng Ma, Song Wang, Shanglong Liu, Wenchang Yang, Jilin Hu, Lianghong Lv, Qian Yu, Yun Lu. Metabolic syndrome in colorectal cancer liver metastasis: metabolic reprogramming and microenvironment crosstalk. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1653442
|
| 35 |
Zhao-Chun Chi. Progress in undestanding of relationship between P2X7R and pancreatic ductal adenocarcinoma. World Chinese Journal of Digestology 2025; 33(8) doi: 10.11569/wcjd.v33.i8.599
Abstract(163) |
Core Tip(151) |
Full Article(HTML)(478)
|
Times Cited (0)
|
Total Visits (807)
|
Open
|
| 36 |
Varun Suryadevara, Ayan Roy, Jayaprakash Sahoo, Sadishkumar Kamalanathan, Dukhabandhu Naik, Pazhanivel Mohan, Raja Kalayarasan. Incretin based therapy and pancreatic cancer: Realising the reality. World Journal of Gastroenterology 2022; 28(25): 2881-2889 doi: 10.3748/wjg.v28.i25.2881
|
| 37 |
Marina M. Charitou, Huda Al-Bahadili. Diabetes Management in Hospitalized Patients. Contemporary Endocrinology 2023; doi: 10.1007/978-3-031-44648-1_15
|
| 38 |
Yunda Song, Lingmin Jiang, Yuanxia Han, Subo Zhang, Shengping Li. Triglyceride-glucose index and glycemic dynamics in pancreatic ductal adenocarcinoma: implications for disease progression and prognosis. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05524-w
|
| 39 |
Natalia Pawelec, Łukasz Durko, Ewa Małecka-Wojciesko. Changes Connected to Early Chronic Pancreatitis and Early Pancreatic Cancer in Endoscopic Ultrasonography (EUS): Clinical Implications. Cancers 2025; 17(11) doi: 10.3390/cancers17111891
|
| 40 |
Eliska Selinger, Charlotta Rylander, Guri Skeie. Dietary patterns in relation to incidence rate of pancreatic cancer – the Norwegian women and cancer cohort study. Food & Nutrition Research 2023; 67 doi: 10.29219/fnr.v67.9536
|
| 41 |
Yusuke Takasaki, Hironao Okubo, Yuka Fukuo, Muneo Ikemura, Hitoshi Ando, Hiroyuki Isayama. Gadoxetic acid-enhanced magnetic resonance imaging predicts early nab-paclitaxel-induced peripheral neuropathy during pancreatic cancer treatment: A pilot study. Journal of Pharmacological Sciences 2025; 158(2) doi: 10.1016/j.jphs.2025.03.009
|
| 42 |
Guozhong Zheng, Changqing Wei, Kang Li. Determining the summer indoor design parameters for pensioners’ buildings based on the thermal requirements of elderly people at different ages. Energy 2022; 258 doi: 10.1016/j.energy.2022.124854
|
| 43 |
In Rae Cho, Sung Hoon Chang, Sang Hyub Lee, Kyung-Do Han, Kwang Hyun Chung, Min Woo Lee, Jin Ho Choi, Woo Hyun Paik, Ji Kon Ryu. Pancreatic Cystic Neoplasm Risk Among Individuals With Diabetes. JAMA Network Open 2026; 9(2) doi: 10.1001/jamanetworkopen.2025.56951
|
| 44 |
Yong Cheng, Yu-Xi Cheng, Xiao-Yu Liu, Bing Kang, Wei Tao, Dong Peng. The Effect of Type 2 Diabetes Mellitus on the Short-Term Outcomes and Prognosis of Stage I–III Colorectal Cancer: A Propensity Score Matching Analysis. Cancer Management and Research 2022; doi: 10.2147/CMAR.S347242
|
| 45 |
Maja Mejza, Anna Bajer, Sora Wanibuchi, Ewa Małecka-Wojciesko. Can AI Be Useful in the Early Detection of Pancreatic Cancer in Patients with New-Onset Diabetes?. Biomedicines 2025; 13(4) doi: 10.3390/biomedicines13040836
|
| 46 |
Miłosz Caban, Ewa Małecka-Wojciesko. Gaps and Opportunities in the Diagnosis and Treatment of Pancreatic Cancer. Cancers 2023; 15(23) doi: 10.3390/cancers15235577
|
| 47 |
Jan Bures, Darina Kohoutova, Jan Skrha, Bohus Bunganic, Ondrej Ngo, Stepan Suchanek, Pavel Skrha, Miroslav Zavoral. Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus. Cancers 2023; 15(14) doi: 10.3390/cancers15143669
|
| 48 |
Iman Mohammad Said Jallod, Ammar Khalo Abbas, Faheemah Ismael Yaqoob, Abdul-Aziz Ahmed Aziz. Bridging diabetes and cancer: harnessing biomarkers as dual sentinels for diagnosis, prognosis, and therapeutic advancements. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(11) doi: 10.1007/s00210-025-04209-5
|
| 49 |
Jiaqi Han, Qianping Liang, Yaqi Lv, Hongli Chen, Xiaoyu Lei, Chan Liao, Shaoqi Yang, Feifei Chu. Global, regional, and national analyses of the burden of pancreatic cancer attributable to high fasting plasma glucose from 1990 to 2021: A longitudinal observational study. Medicine 2026; 105(16) doi: 10.1097/MD.0000000000048315
|
| 50 |
Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Pragya Bradu, Aarthi Sukumar, Megha Patil, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, Alex George, Raja Ganesan. Implications of cancer stem cells in diabetes and pancreatic cancer. Life Sciences 2023; 312 doi: 10.1016/j.lfs.2022.121211
|
| 51 |
Shahab Hajibandeh, Christina Intrator, Eliot Carrington-Windo, Rhodri James, Ioan Hughes, Shahin Hajibandeh, Thomas Satyadas. Accuracy of the END-PAC Model in Predicting the Risk of Developing Pancreatic Cancer in Patients with New-Onset Diabetes: A Systematic Review and Meta-Analysis. Biomedicines 2023; 11(11) doi: 10.3390/biomedicines11113040
|
| 52 |
María Victoria Mencucci, Martín Carlos Abba, Bárbara Maiztegui. Decoding the role of microRNA dysregulation in the interplay of pancreatic cancer and type 2 diabetes. Molecular and Cellular Endocrinology 2024; 583 doi: 10.1016/j.mce.2023.112144
|
| 53 |
Ga Hyun Lee, Yeon Hee Kim, Sang Myung Woo, Woo Jin Lee, Sung-Sik Han, Sang-Jae Park, Sherry Price, Penias Tembo, James R. Hébert, Mi Kyung Kim. The Impact of the Dietary Inflammatory Index, Fasting Blood Glucose, and Smoking Status on the Incidence and Survival of Pancreatic Cancer: A Retrospective Case–Control Study and a Prospective Study. Nutrients 2024; 16(22) doi: 10.3390/nu16223941
|
| 54 |
Araceli Fuentes, Josep Montserrat-Capdevila, Didac Florensa, Sofia Godoy, Judith Serrano, Pere Godoy. The Diabetes-Pancreatic Cancer Risk Relationship over Time: A Systematic Review and Meta-Analysis. Diabetology 2025; 6(11) doi: 10.3390/diabetology6110131
|
| 55 |
Steven Grewe, Markus S. Jördens, Christoph Roderburg, Catherine Leyh, Simon Labuhn, Tom Luedde, Sarah Krieg, Andreas Krieg, Sven H. Loosen, Karel Kostev. Elevated HbA1c Levels Are Associated with a Risk of Pancreatic Cancer: A Case–Control Study. Journal of Clinical Medicine 2024; 13(18) doi: 10.3390/jcm13185584
|
| 56 |
Yihao Liu, Jiayu Lin, Zhengwei Yu, Xueying Li, Xueqi Lv, Pengyi Liu, Xiuqiao Sun, Zhen Zhang, Xia Gao, Keyan Sun, Dan Li, Jingfeng Li, Yang Liu, Yu Jiang, Siyi Zou, Jianping Lin, Baofa Sun, Da Fu, Baiyong Shen. Tumor-associated Schwann cell remodeling under metabolic stress via lactate sensing orchestrates pancreatic ductal adenocarcinoma development. Cell Metabolism 2025; 37(9) doi: 10.1016/j.cmet.2025.07.008
|
| 57 |
Lara Magni, Haoran Yu, Nynne M. Christensen, Mette H. Poulsen, Alexander Frueh, Ganga Deshar, Astrid Z. Johansen, Julia S. Johansen, Stephan A. Pless, Niklas R. Jørgensen, Ivana Novak. Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer. Cancer Cell International 2024; 24(1) doi: 10.1186/s12935-024-03339-9
|
| 58 |
Na Su, Rui Tang, Yice Zhang, Jiaqi Ni, Yimei Huang, Chunqi Liu, Yuzhou Xiao, Baoting Zhu, Yinglan Zhao. Using machine learning to identify risk factors for pancreatic cancer: a retrospective cohort study of real-world data. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1510220
|
| 59 |
. 2025; doi: 10.51168/sjhrafrica.v6i3.1493
|
| 60 |
Taymin du Toit-Thompson, Lionel Leck, Josef Gillson, Nick Pavlakis, Anthony J. Gill, Jaswinder S. Samra, Anubhav Mittal, Sumit Sahni. Overcoming therapy resistance in pancreatic cancer: challenges and emerging strategies. Advanced Drug Delivery Reviews 2025; 224 doi: 10.1016/j.addr.2025.115647
|
| 61 |
O. P. Shesternikova, V. K. Finn, K. A. Lesko, L. V. Vinokurova. Application of the JSM Method of Automated Research Support to Predict Diabetes Development in Patients with Chronic Pancreatitis. Automatic Documentation and Mathematical Linguistics 2023; 57(2) doi: 10.3103/S0005105523020085
|
| 62 |
Yunus GÜR, Egemen TURAL, Akın DAYAN. Exploring Perspectives on Cancer Screening in People Aged 30-70: A Comparative Study of Those With and Without Type 2 Diabetes. Konuralp Tıp Dergisi 2024; 16(1) doi: 10.18521/ktd.1392977
|
| 63 |
Akhil Jain, Praneeth Reddy Keesari, Yashwitha Sai Pulakurthi, Rewanth Katamreddy, Meekoo Dhar, Rupak Desai. Pancreatic Cancer Risk in Prediabetes. Pancreas 2025; 54(1) doi: 10.1097/MPA.0000000000002391
|
| 64 |
Meitong Guo, Qi Han, Zixi Wang, Dong Ya, Xiaoyan Wang. Research progress on the etiology and pathogenesis of pancreatic cancer: a narrative review. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1781024
|
| 65 |
A. S. Ametov, A. V. Shabunin, E. Yu. Pashkova, M. M. Tavobilov, A. A. Karpov, I. I. Golodnikov, K. A. Amikishieva. Carbohydrate metabolism in patients after pancreatoduodenal resection. Meditsinskiy sovet = Medical Council 2022; (14) doi: 10.21518/2079-701X-2022-16-14-120-126
|
| 66 |
Nicolette Casarcia, Patrick Rogers, Emma Guld, Samvit Iyer, Yutong Li, Jack T. Burcher, Lindsay K. DeLiberto, Sabyasachi Banerjee, Anupam Bishayee. Phytochemicals for the prevention and treatment of pancreatic cancer: Current progress and future prospects. British Journal of Pharmacology 2025; 182(10) doi: 10.1111/bph.16249
|
| 67 |
I. V. Druk. Pancreatic cancer, pancreatogenic diabetes, type 2 diabetes mellitus. Experimental and Clinical Gastroenterology 2022; (9) doi: 10.31146/1682-8658-ecg-205-9-171-182
|
| 68 |
Jie Yang, Chengming Wen, Hongkai Guo, Yahui Chai, Guodong Sun, Huijuan Cheng. Targeting early diagnosis and treatment of pancreatic cancer among the diabetic population: a comprehensive review of biomarker screening strategies. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01750-4
|
| 69 |
Sophia Tsokkou, Ioannis Konstantinidis, Maria-Nefeli Georgaki, Dimitrios Kavvadas, Kyriaki Papadopoulou, Antonios Keramas, Antonia Sioga, Theodora Papamitsou, Sofia Karachrysafi. Gestational Diabetes Mellitus and Its Correlation in the Development of Pancreatic Cancer: A 10-Year Systematic Review. Cancers 2024; 16(10) doi: 10.3390/cancers16101840
|
| 70 |
Ya. V. Dvoryanchikov, S. M. Deunezhewa, I. A. Yatskov, V. A. Beloglazov. Overview of the prevalence and features of oncological diseases in type 2 diabetes and possible immunological mechanisms. Problems of Endocrinology 2025; 71(2) doi: 10.14341/probl13452
|
| 71 |
Helen B. Binang, Chamini J. Perera, Minoti V. Apte. Role of Pancreatic Tumour-Derived Exosomes and Their Cargo in Pancreatic Cancer-Related Diabetes. International Journal of Molecular Sciences 2023; 24(12) doi: 10.3390/ijms241210203
|
| 72 |
Francisco Josué Cordero Pérez, Pablo Rodríguez López, Paula Oleaga Gómez, Marta Antona Herranz, Eva Purificación Martín Garrido. Poorly Controlled New-Onset Diabetes Mellitus and Other Atypical Signs as an Early Sign of Pancreatic Adenocarcinoma. Cureus 2024; doi: 10.7759/cureus.62319
|
| 73 |
Peng-Jiong Liu, Zhi-Peng Zhou, Guan-Yu Wang, Shuai Xu, Wei Wang, Xiong Chen, Xiao-Dong Tan, Zhong-Hua Liu, Zhi-Ming Zhao, Yuan-Xing Gao, Xiu-Ping Zhang, Rong Liu. New-onset diabetes worsens prognosis of patients with pancreatic ductal adenocarcinoma after R0 resection: A multicenter study. Hepatobiliary & Pancreatic Diseases International 2025; 24(5) doi: 10.1016/j.hbpd.2025.04.008
|
| 74 |
Maria V. Deligiorgi, Dimitrios T. Trafalis. A Concerted Vision to Advance the Knowledge of Diabetes Mellitus Related to Immune Checkpoint Inhibitors. International Journal of Molecular Sciences 2023; 24(8) doi: 10.3390/ijms24087630
|
| 75 |
Mariusz Dąbrowski, Mariusz Partyka, Krzysztof Gutkowski, Lilianna Kołodziej-Spirodek, Anna Juza. Distinguishing exocrine pancreas disease-associated diabetes from type 2 diabetes based on anthropometric and metabolic parameters. World Journal of Diabetes 2025; 16(2): 95102 doi: 10.4239/wjd.v16.i2.95102
|
| 76 |
Wei Ting Wang, Sudha Harikrishnan, Xiaozhu Zhang, Tony Lim, Yong Mong Bee, Khung Keong Yeo, Joan Joo Ching Khoo, Lynette Mei Yi Lee, Gilbert Choon Seng Tan, Hong Chang Tan. Epidemiology of pancreatic cancer in patients with diabetes mellitus. Singapore Medical Journal 2026; doi: 10.4103/singaporemedj.SMJ-2024-223
|
| 77 |
Catharina B.P. Villaca, Teresa L. Mastracci. Comprehensive Physiology. 2024; doi: 10.1002/cphy.c230008
|
| 78 |
FERRAN CORDÓN GRANADOS, MERITXELL SAURA PARRAMON. Cáncer de páncreas. Actualización en Medicina de Familia 2024; doi: 10.55783/AMF.200404
|
| 79 |
Xianglin Zhu, Lang Wang, Hao Liang, Jie Zhang, Shijun Zhao, Cheng Zhao, Dehai Wang, Yinlu Ding. Global burden of cancers attributable to high fasting plasma glucose from 1990 to 2021 and projections until 2031. Diabetology & Metabolic Syndrome 2026; 18(1) doi: 10.1186/s13098-025-02074-z
|
| 80 |
Mirela Dănilă, Ana-Maria Ghiuchici, Renata Bende, Iulia Rațiu, Felix Bende. Pancreatic Cancer Screening in Patients with Type 2 Diabetes Mellitus: A Narrative Review. Medicina 2025; 62(1) doi: 10.3390/medicina62010067
|
| 81 |
Fabrício Freire de Melo, Gabriel Reis Rocha, Gabriel Lima Correa Santos, Mariana dos Santos Calmon, Samuel Luca Rocha Pinheiro, Marcel Silva Luz, Fabian Fellipe Bueno Lemos, Luis Guilherme de Oliveira Silva. New avenues for the treatment of immunotherapy-resistant pancreatic cancer. World Journal of Gastrointestinal Oncology 2024; 16(4): 1134-1153 doi: 10.4251/wjgo.v16.i4.1134
|